THE SENESCENT SLAYER

FOXO4-DRI

Grade CModerate

Senolytic peptide that selectively eliminates zombie cells

Also known as: -

Senolytic
Anti-Aging & Longevity
Organ Protection

Overview

FOXO4-DRI is a senolytic peptide designed to selectively kill senescent "zombie" cells - old, damaged cells that refuse to die and instead pump out inflammatory signals that age surrounding tissue. It works by disrupting the FOXO4-p53 interaction that keeps these cells alive. In mice, it reversed aspects of aging.

Key Benefits & Mechanisms

FOXO4-p53 Disruption

Breaks the bond keeping senescent cells alive

Selective Apoptosis

Triggers death only in senescent cells, sparing healthy ones

SASP Reduction

Reduces inflammatory signals from senescent cells

Dosing Guide

Dosage

No established human dosing

Schedule

daily

Cycle

Experimental - cycle with nutritional support

Pro Tip

Research compound only; anecdotal human use reported online

Safety Profile

C

Moderate Safety

Moderate

Well-tolerated in animal studies. Very limited human data.

Experimental compound. No established human dosing. Self-experimenters report hot flashes. Ensure good nutrition during use.

Possible Side Effects

Hot flashes
Increased perspiration

What to Expect

During treatment

Senescent cells begin apoptosis

Post-treatment

Reduced inflammation as senescent cells clear

Long-term

Potential tissue rejuvenation (observed in mice)

Effects in mice observed after treatment course; human timeline unknown.

Who Is This For

Longevity researchers and enthusiasts
Those interested in senolytic therapy
People with age-related organ decline
Anyone wanting to clear senescent cells
Anti-aging focused individuals

Research References

Related Peptides

Ready to Start Your Peptide Journey?

Track your protocols, get guided reconstitution, and access our vetted vendor network — all in one app.

Download The Peptide App